Skip navigation
Agenda

Managing High-Priority Risks and Aligning Compliance with Business Innovation

November 13-14, 2019
  • London, United Kingdom

Agenda

Want more agenda details? Download the brochure.

DAY ONE Wednesday, 13 November 2019

8:15

Conference Registration and Welcome Refreshments

8:45

Co-Chairs’ Welcome and Opening Remarks

Betania Glorio
Global Compliance Officer Healthcare
Merck KGaA

Maike Bermueller
Head of Ethics & Compliance Human Pharma
Boehringer Ingelheim

9:00

CROSS-INDUSTRY SPOTLIGHT — FIRESIDE CHAT Journey to the Dark Side of International Business
and Steps to Protect Your Organisation

IN CONVERSATION WITH:

Richard Bistrong
CEO
Front-Line Anti-Bribery LLC;
Former FCPA Violator and FBI/UK Cooperator

INTERVIEWED BY:

Malene Abildstrøm
Director, Head of Ethics & Compliance, Nordic Operations
Astellas Pharma

9:45

PANEL DISCUSSION Risky Business — How Third-Party Relationships
Can Define Your Company’s Reputation

PANELISTS

Evgeny Tilezhinsky
Global Expansion Business Partner, Office of Business
Integrity and Ethics
Vertex Pharmaceuticals

Niels Wohlwend
Senior Director HCC Europe & Canada, Global Compliance Group
Celgene

10:30

Networking and Refreshment Break

11:00

Transparency and Disclosure Around the World

Munish Duvedi
Consultant
GCO Global

Klaus Geldsetzer
Chief Compliance Officer EMEA
Santen GmbH

12:00 Leadership Summit

Legal and Compliance
Leadership Summit

2019 Theme: Compliance as a Role Model

13:15 Summit Host Welcome

This summit is designed to encourage an open exchange of ideas and strategies surrounding some of the most critical issues facing heads of compliance across the life sciences industry. The host facilitates discussions surrounding key questions, challenges and issues. Participants benefit from exclusive networking with peers, sharing concerns and acquiring additional best practices for enriching their compliance programmes.

DIALOGUE DRIVERS:

I.Essential Skills of a Compliance Manager
II.Why Friction and How to Handle Friction
III.Why Ethics?
IV.KPIs…for Whom?
V.Who Owns Ethics & Compliance?

SUMMIT LEADER:

Michaela Ahlberg
Chief Ethics & Compliance Officer
Getinge

14:45

Close of Leadership Summit & Return to General Sessions

*Participants hold the title of Chief Compliance Officer, Vice President of Compliance, General Counsel or an equivalent compliance leadership position at a life sciences company (at the time of the conference). Final eligibility approval is at the discretion of CBI.

12:00

Networking Luncheon

13:15

Risk Assessment and Mitigation with Limited Resources and Short Attention Spans

Dumitru Uta
Ethics and Compliance Director
Lilly South-East Europe

14:00

GDPR BENCHMARKING What Are the Lessons Learned After 18 Months of GDPR?

James Clark
Senior Associate
DLA Piper

14:45

Networking and Refreshment Break

15:15

Delivering Online Training for Enhanced Compliance

Richard Hodgins
Chief Technology Officer
Intuition(invited)

16:00

PANEL DISCUSSION Structuring Compliant Digital Communications in the Age of 5G Technology

PANELISTS:

Malene Abildstrøm
Director, Head of Ethics & Compliance, Nordic Operations
Astellas Pharma

Nicola Giovinazzi
Corporate Compliance Director
MENARINI Group

Ursula Hohlneicher
General Manager Compliance
AstraZeneca

17:00

Close of Day One

Networking, Wine and Cheese Reception immediately following the final session on day one

DAY TWO Thursday, 14 November 2019

8:15

Morning Refreshments

8:45

Co-Chairs’ Review of Day One

Betania Glorio
Global Compliance Officer Healthcare
Merck KGaA

Maike Bermueller
Head of Ethics & Compliance Human Pharma
Boehringer Ingelheim

9:00

EXPERT Q&A Compliance for the Beginner and the Expert — What You Need to Know and What You Wish You Had Known

INTERVIEW WITH:

Alessandra Hawthorne
Head, Corporate Department Ethics & Compliance,
Global Chief Ethics and Compliance Officer
Boehringer Ingelheim

INTERVIEWED BY:

John P. Oroho
Principal
Porzio, Bromberg & Newman;
Executive Vice President, Chief Strategy Officer
Porzio Life Sciences, LLC

10:00

COLLABORATIVE CO-PRESENTATIONExamine the Impact of Whistleblower Protection in the EU

David Eves
Head of Compliance
Chugai Pharma Europe Ltd

Gareth Rees
Partner, Special Matters and Government Investigations
King & Spalding

10:45

Networking and Refreshment Break

11:15

INSIGHTFUL DISCUSSIONWorking Together — Integrating the Patient Voice While Ensuring Patient Rights

Nicola Giovinazzi
Corporate Compliance Director
MENARINI Group

Kim Smith
Compliance Manager, UK and Ireland
Merck Group

12:00

Networking Luncheon

13:00

Global Oversight with Data Analytics in an Evolving Ecosystem

Speaker TBA

13:45

Compare Strategies for Managing HCP Sponsorships and Grants

Ariadna Quesada
Compliance Director, EMEA
HillRom

14:30

Close of Conference

Agenda

Want more agenda details? Download the brochure.

Want more agenda details? Download the brochure.

DAY ONE Wednesday, 13 November 2019

8:15

Conference Registration and Welcome Refreshments

8:45

Co-Chairs’ Welcome and Opening Remarks

Betania Glorio
Global Compliance Officer Healthcare
Merck KGaA

Maike Bermueller
Head of Ethics & Compliance Human Pharma
Boehringer Ingelheim

9:00

CROSS-INDUSTRY SPOTLIGHT — FIRESIDE CHAT Journey to the Dark Side of International Business
and Steps to Protect Your Organisation

IN CONVERSATION WITH:

Richard Bistrong
CEO
Front-Line Anti-Bribery LLC;
Former FCPA Violator and FBI/UK Cooperator

INTERVIEWED BY:

Malene Abildstrøm
Director, Head of Ethics & Compliance, Nordic Operations
Astellas Pharma

9:45

PANEL DISCUSSION Risky Business — How Third-Party Relationships
Can Define Your Company’s Reputation

PANELISTS

Evgeny Tilezhinsky
Global Expansion Business Partner, Office of Business
Integrity and Ethics
Vertex Pharmaceuticals

Niels Wohlwend
Senior Director HCC Europe & Canada, Global Compliance Group
Celgene

10:30

Networking and Refreshment Break

11:00

Transparency and Disclosure Around the World

Munish Duvedi
Consultant
GCO Global

Klaus Geldsetzer
Chief Compliance Officer EMEA
Santen GmbH

12:00 Leadership Summit

Legal and Compliance
Leadership Summit

2019 Theme: Compliance as a Role Model

13:15 Summit Host Welcome

This summit is designed to encourage an open exchange of ideas and strategies surrounding some of the most critical issues facing heads of compliance across the life sciences industry. The host facilitates discussions surrounding key questions, challenges and issues. Participants benefit from exclusive networking with peers, sharing concerns and acquiring additional best practices for enriching their compliance programmes.

DIALOGUE DRIVERS:

I.Essential Skills of a Compliance Manager
II.Why Friction and How to Handle Friction
III.Why Ethics?
IV.KPIs…for Whom?
V.Who Owns Ethics & Compliance?

SUMMIT LEADER:

Michaela Ahlberg
Chief Ethics & Compliance Officer
Getinge

14:45

Close of Leadership Summit & Return to General Sessions

*Participants hold the title of Chief Compliance Officer, Vice President of Compliance, General Counsel or an equivalent compliance leadership position at a life sciences company (at the time of the conference). Final eligibility approval is at the discretion of CBI.

12:00

Networking Luncheon

13:15

Risk Assessment and Mitigation with Limited Resources and Short Attention Spans

Dumitru Uta
Ethics and Compliance Director
Lilly South-East Europe

14:00

GDPR BENCHMARKING What Are the Lessons Learned After 18 Months of GDPR?

James Clark
Senior Associate
DLA Piper

14:45

Networking and Refreshment Break

15:15

Delivering Online Training for Enhanced Compliance

Richard Hodgins
Chief Technology Officer
Intuition(invited)

16:00

PANEL DISCUSSION Structuring Compliant Digital Communications in the Age of 5G Technology

PANELISTS:

Malene Abildstrøm
Director, Head of Ethics & Compliance, Nordic Operations
Astellas Pharma

Nicola Giovinazzi
Corporate Compliance Director
MENARINI Group

Ursula Hohlneicher
General Manager Compliance
AstraZeneca

17:00

Close of Day One

Networking, Wine and Cheese Reception immediately following the final session on day one

DAY TWO Thursday, 14 November 2019

8:15

Morning Refreshments

8:45

Co-Chairs’ Review of Day One

Betania Glorio
Global Compliance Officer Healthcare
Merck KGaA

Maike Bermueller
Head of Ethics & Compliance Human Pharma
Boehringer Ingelheim

9:00

EXPERT Q&A Compliance for the Beginner and the Expert — What You Need to Know and What You Wish You Had Known

INTERVIEW WITH:

Alessandra Hawthorne
Head, Corporate Department Ethics & Compliance,
Global Chief Ethics and Compliance Officer
Boehringer Ingelheim

INTERVIEWED BY:

John P. Oroho
Principal
Porzio, Bromberg & Newman;
Executive Vice President, Chief Strategy Officer
Porzio Life Sciences, LLC

10:00

COLLABORATIVE CO-PRESENTATIONExamine the Impact of Whistleblower Protection in the EU

David Eves
Head of Compliance
Chugai Pharma Europe Ltd

Gareth Rees
Partner, Special Matters and Government Investigations
King & Spalding

10:45

Networking and Refreshment Break

11:15

INSIGHTFUL DISCUSSIONWorking Together — Integrating the Patient Voice While Ensuring Patient Rights

Nicola Giovinazzi
Corporate Compliance Director
MENARINI Group

Kim Smith
Compliance Manager, UK and Ireland
Merck Group

12:00

Networking Luncheon

13:00

Global Oversight with Data Analytics in an Evolving Ecosystem

Speaker TBA

13:45

Compare Strategies for Managing HCP Sponsorships and Grants

Ariadna Quesada
Compliance Director, EMEA
HillRom

14:30

Close of Conference